Lamivir 150mg (Lamivudine)

Description

Lamivir 150mg (Lamivudine 150mg) Tablets

Lamivir 150mg contains lamivudine 150mg, an antiviral medicine in the nucleoside reverse transcriptase inhibitor (NRTI) class. Lamivudine is used with other antiretroviral medicines to treat HIV-1 infection. The product shown here is Lamivir-150 from Cipla.

Lamivir 150mg Lamivudine: What Is It?

Lamivir 150mg is a prescription tablet containing lamivudine 150mg. Cipla markets Lamivir 150 as a lamivudine product, and current Indian pharmacy listings identify the same active ingredient and strength.

Lamivudine is also known as 3TC. It belongs to the NRTI class of antiretroviral medicines.

Importantly, lamivudine should normally form part of an appropriate combination HIV treatment regimen. It should not be used alone to treat HIV because inadequate therapy can allow viral resistance to develop.

Lamivir 150mg Lamivudine Uses

Lamivir 150mg contains lamivudine, which is used in combination with other antiretroviral medicines for the treatment of HIV-1 infection.

Lamivudine works by reducing HIV replication. As a result, combination antiretroviral therapy can lower the amount of HIV in the blood and support immune function.

However, lamivudine does not cure HIV. Therefore, patients should continue treatment exactly as prescribed even when they feel well.

What Is Lamivudine Used For?

Lamivudine is primarily used as part of antiretroviral therapy for HIV-1. It is also an antiviral ingredient used in certain medicines for chronic hepatitis B.

Nevertheless, the formulation and strength matter. The current U.S. 150mg/300mg lamivudine tablets are labeled for HIV-1 treatment, while the lower-dose HBV formulation has different labeling.

For that reason, do not assume that every lamivudine product can be substituted for another lamivudine formulation.

How Does Lamivir 150mg Lamivudine Work?

Lamivudine inhibits HIV reverse transcriptase. This enzyme is required for HIV to convert its genetic material into DNA.

After lamivudine becomes active inside cells, it interferes with viral DNA synthesis. Consequently, the medicine helps reduce HIV replication.

Lamivudine does not remove HIV from the body. Instead, it works as one component of combination antiretroviral therapy.

Lamivir 150mg Composition

• Active ingredient: Lamivudine
• Strength: 150mg
• Dosage form: Tablet
• Drug class: Nucleoside reverse transcriptase inhibitor
• Other name: 3TC
• Brand: Lamivir-150
• Manufacturer/marketer: Cipla

Lamivudine 150mg Dose

The appropriate lamivudine dose depends on the treatment regimen, age, body weight, kidney function, and other medicines.

For adults with HIV-1 infection, the current U.S. lamivudine tablet label recommends a total daily dose of 300mg. This can be given as either:

• 150mg twice daily, or
• 300mg once daily.

The medicine can be taken with or without food.

Patients with reduced kidney function may require dosage adjustment. Therefore, healthcare professionals should assess renal function before selecting the appropriate dose.

For current prescribing information, see the DailyMed lamivudine prescribing information.

How to Take Lamivir 150mg

Take Lamivir exactly as prescribed. Your healthcare professional will determine whether the prescribed regimen uses once-daily or twice-daily dosing.

• Take the medicine at approximately the same time each day.
• You can take lamivudine with or without food.
• Swallow the tablet as directed.
• Continue your other prescribed HIV medicines.
• Do not change the regimen without medical advice.

Consistency matters because missed doses can reduce treatment effectiveness and may contribute to resistance.

Lamivir 150mg Lamivudine Side Effects

Lamivudine can cause side effects, although not everyone experiences them.

Possible reactions may include:

• Headache
• Nausea
• Diarrhea
• Tiredness
• Digestive discomfort
• Muscle or joint discomfort

Side effects vary between individuals. Therefore, tell your healthcare professional if a symptom persists or becomes difficult to manage.

Serious Lamivudine Side Effects

Lamivudine has important safety warnings. Rare but serious problems can include lactic acidosis and severe liver enlargement with fatty liver.

Seek urgent medical attention for symptoms such as:

• Severe weakness or unusual tiredness
• Persistent nausea or vomiting
• Severe abdominal discomfort
• Difficulty breathing
• Unusual muscle pain
• Yellowing of the skin or eyes
• Dark urine

People with hepatitis B require additional caution because stopping lamivudine can trigger a severe worsening of HBV infection.

Lamivudine and Hepatitis B

Lamivudine also has antiviral activity against hepatitis B virus. However, the 150mg HIV formulation should not automatically be treated as equivalent to the specific HBV formulation.

Current U.S. labeling distinguishes HIV lamivudine tablets from the lower-dose HBV formulation. Consequently, patients with chronic hepatitis B should use the formulation and dose prescribed for their condition.

MedlinePlus warns that people with HBV can experience a sudden worsening of hepatitis B after stopping lamivudine. Therefore, medical monitoring remains important when treatment changes.

For additional information, see MedlinePlus Lamivudine Drug Information.

Lamivir 150mg and HIV Treatment

Lamivudine is commonly combined with other antiretroviral medicines. The exact combination depends on current HIV treatment guidelines, resistance history, other medical conditions, and previous therapy.

For example, lamivudine can appear in regimens containing an integrase inhibitor or another NRTI. Therefore, Lamivir 150mg should not be considered a complete HIV treatment regimen by itself.

Lamivudine and Dolutegravir

Dolutegravir plus lamivudine is a combination used in certain HIV treatment settings.

Dolutegravir belongs to the integrase strand transfer inhibitor class, while lamivudine belongs to the NRTI class. Together, they target HIV through different mechanisms.

However, not every patient is suitable for a two-drug regimen. Therefore, treatment selection should follow current HIV guidelines and individual clinical assessment.

Lamivudine and Zidovudine

Lamivudine can also be combined with zidovudine, another NRTI. Combination products containing lamivudine and zidovudine have been used in HIV treatment.

Nevertheless, current HIV treatment has evolved considerably. Healthcare professionals now select antiretroviral combinations according to current guidelines, resistance, tolerability, interactions, and patient-specific factors.

Lamivudine and Abacavir

Lamivudine is also available in combination with abacavir. Some HIV treatment products combine abacavir and lamivudine with an additional antiretroviral medicine.

Before using abacavir-containing therapy, healthcare professionals may consider genetic testing and other safety factors. Therefore, patients should not start such combinations without appropriate medical evaluation.

Lamivudine and Tenofovir

Lamivudine and tenofovir can appear together in HIV treatment regimens. Both medicines belong to the NRTI family, although they contain different active ingredients.

Importantly, the appropriate combination depends on current HIV guidelines and the patient’s complete treatment history.

For example, the U.S. FDA lists lamivudine and tenofovir disoproxil fumarate together in certain combination HIV medicines. :contentReference[oaicite:2]{index=2}

Lamivudine and Emtricitabine

Lamivudine and emtricitabine are both NRTIs with similar antiviral activity. However, they are different active ingredients.

Healthcare professionals generally select one or the other within an appropriate regimen rather than combining them routinely. Consequently, patients should not add emtricitabine to a lamivudine-containing regimen without medical advice.

Lamivudine and Nevirapine

Lamivudine has historically been used with nevirapine and other antiretroviral medicines. However, modern HIV treatment often favors newer regimens with improved tolerability, resistance profiles, and convenience.

Therefore, the most appropriate combination should be selected using current clinical guidance.

Lamivudine and Efavirenz

Lamivudine has also been used in regimens containing efavirenz. However, treatment recommendations can change as newer HIV medicines become available.

For that reason, patients should follow their current prescribed regimen rather than relying on an older combination.

Lamivudine Drug Class

Lamivudine belongs to the nucleoside reverse transcriptase inhibitor (NRTI) class.

Other medicines in or related to the NRTI group include zidovudine, abacavir, and tenofovir products. Each medicine has its own dosing, interactions, warnings, and clinical role.

Lamivudine 150mg and Kidney Function

Kidney function affects how lamivudine leaves the body. Therefore, people with reduced kidney function may need a lower dose or a different dosing interval.

Tell your healthcare professional if you have kidney disease or receive dialysis. Appropriate renal assessment can help reduce the risk of excessive drug exposure.

Lamivudine and Liver Disease

Tell your healthcare professional if you have liver disease or hepatitis B.

Lamivudine treatment requires special attention when HIV and HBV occur together. In particular, stopping lamivudine can cause hepatitis B to flare.

Consequently, patients with HIV and HBV should receive coordinated medical care when changing antiretroviral therapy.

Can Lamivudine Cure HIV?

No. Lamivudine does not cure HIV.

Instead, it helps suppress HIV replication as part of combination antiretroviral therapy. Effective treatment can reduce the amount of HIV in the blood and support immune health.

Patients should continue treatment even when they feel healthy unless their healthcare professional changes the regimen.

What Happens If You Miss a Lamivudine Dose?

If you miss a dose, follow the instructions provided by your healthcare professional or pharmacist. Do not take extra tablets to compensate unless specifically instructed.

Try to take lamivudine at the same time each day. In addition, keep enough medicine available so that treatment is not interrupted unnecessarily.

Can Lamivudine Be Stopped Suddenly?

Do not stop Lamivir without medical advice.

Stopping lamivudine can allow HIV to rebound and may contribute to drug resistance. Furthermore, people who also have hepatitis B can experience a serious HBV flare after stopping therapy.

Therefore, discuss any treatment change with your healthcare professional first.

Lamivudine During Pregnancy

Tell your healthcare professional if you are pregnant, planning pregnancy, or breastfeeding.

Pregnancy can influence HIV treatment decisions. Therefore, people who are pregnant should receive individualized advice about the safest and most effective antiretroviral regimen.

Do not stop HIV treatment independently because of pregnancy. Instead, discuss the treatment plan with an HIV specialist or qualified healthcare professional.

Lamivudine and Breastfeeding

Discuss breastfeeding with your healthcare professional before starting or continuing lamivudine.

HIV treatment and infant-feeding recommendations depend on the individual’s circumstances and current clinical guidance. Therefore, follow specialist advice.

Lamivudine Drug Interactions

Tell your doctor and pharmacist about all prescription medicines, over-the-counter medicines, vitamins, supplements, and herbal products that you use.

Lamivudine can interact with certain medicines or require dose adjustment in specific circumstances. Kidney function also affects dosing.

Therefore, do not start a new medicine or supplement without checking whether it fits your treatment plan.

Lamivudine 150mg Price

The price of Lamivir 150mg can vary by country, pharmacy, pack size, taxes, supplier, and availability.

Online prices may change over time. Therefore, check the current price and availability before ordering.

Price should not be the only consideration when choosing prescription medicine. Product authenticity, appropriate storage, legal dispensing, and medical supervision are also important.

How Should Lamivir 150mg Be Stored?

Store Lamivir according to the instructions on the product packaging.

• Keep the tablets in their original packaging.
• Protect the medicine from excessive moisture.
• Store it at the temperature recommended on the label.
• Keep all medicines away from children and pets.
• Do not use tablets if the packaging is damaged or the product appears abnormal.

Lamivir 150mg Frequently Asked Questions

What is Lamivir 150mg?

Lamivir 150mg is a prescription tablet containing lamivudine 150mg. Cipla markets Lamivir 150 as a lamivudine product.

What is Lamivudine 150mg used for?

Lamivudine 150mg is used as part of combination antiretroviral treatment for HIV-1. Lamivudine is also used in specific formulations for chronic hepatitis B.

What is lamivudine?

Lamivudine is an antiviral NRTI also known as 3TC. It works by inhibiting viral reverse transcriptase.

Is Lamivir 150mg an HIV medicine?

Yes. Lamivudine 150mg is used as part of combination treatment for HIV-1 infection.

Is Lamivir 150mg a complete HIV treatment?

No. Lamivudine is normally used with other antiretroviral medicines. It should not be used alone to treat HIV.

What is the usual adult lamivudine dose for HIV?

The current U.S. lamivudine tablet label recommends 300mg daily for adults, given as 150mg twice daily or 300mg once daily. Kidney impairment can require dose adjustment.

Can lamivudine be taken with food?

Yes. Lamivudine tablets can be taken with or without food.

What is the lamivudine drug class?

Lamivudine belongs to the nucleoside reverse transcriptase inhibitor class.

Is lamivudine the same as 3TC?

Yes. 3TC is another name for lamivudine.

Can lamivudine cure HIV?

No. Lamivudine helps control HIV as part of combination antiretroviral therapy but does not cure HIV.

Can I stop Lamivir when I feel better?

No. Do not stop treatment without medical advice. Interrupting therapy can allow HIV to rebound and may contribute to resistance.

What is the difference between lamivudine and emtricitabine?

Both are NRTIs, but they are different active ingredients. They are generally selected as components of appropriate combination regimens rather than used together routinely.

What is the difference between lamivudine and zidovudine?

Both are NRTIs, but they are different medicines. Some older or specific HIV regimens combine them, while current treatment choices depend on modern clinical guidance.

U.S. Medical Information for Lamivir 150mg Lamivudine

For reliable information about lamivudine, use authoritative medical sources. These resources provide additional information about indications, dosing, warnings, interactions, and treatment considerations.

• DailyMed – Lamivudine Tablets
  
• MedlinePlus – Lamivudine Drug Information
  
• FDA – HIV and AIDS Medicines
  
• NIH Clinical Guidelines for HIV
  

These external sources can provide more detailed medical information. Always use current prescribing information and professional medical guidance when making treatment decisions.

Explore More Medicines

Visit our online medicine collection to explore other available products.

You can also visit our medicine homepage for additional product information and healthcare resources.

Regulatory Information

Lamivudine is an established prescription antiviral ingredient. However, the regulatory status, formulation, strength, brand name, and approved indication can vary between countries.

Lamivir is a specific Cipla brand and should not automatically be described as FDA-approved simply because lamivudine has approved U.S. products.

The current U.S. 150mg lamivudine tablet label is indicated for HIV-1 treatment in combination with other antiretroviral agents. The label specifically states that this dosage is for HIV-1 and not for HBV.

Important Medical Disclaimer

This page provides general educational information about Lamivir 150mg and lamivudine. It does not replace diagnosis, prescription, or advice from a qualified healthcare professional.

Lamivir 150mg is a prescription medicine. Do not start, stop, or change the dose without professional medical advice.

Patients receiving HIV treatment should use a complete antiretroviral regimen prescribed by a qualified healthcare professional. People with hepatitis B should also receive appropriate monitoring when lamivudine treatment starts, changes, or stops.

Availability, prescribing, dispensing, importation, and use of prescription medicines may be subject to local laws and regulations. Verify legal eligibility and product requirements before ordering.

Always consult a licensed healthcare professional before using Lamivir 150mg.